Association of serum adipocyte fatty acid-binding protein and apolipoprotein B /apolipoprotein A1 ratio with intima media thickness of common carotid artery in dyslipidemic patients
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
30209438
DOI
10.5507/bp.2018.043
Knihovny.cz E-zdroje
- Klíčová slova
- adipocyte fatty acid binding protein, dyslipidemia, intima media thickness,
- MeSH
- apolipoprotein A-I krev MeSH
- apolipoprotein B-100 krev MeSH
- arteria carotis communis diagnostické zobrazování MeSH
- ateroskleróza krev diagnostické zobrazování MeSH
- dospělí MeSH
- dyslipidemie krev diagnostické zobrazování MeSH
- intimomediální šíře tepenné stěny MeSH
- inzulinová rezistence MeSH
- lidé středního věku MeSH
- lidé MeSH
- metabolický syndrom krev diagnostické zobrazování MeSH
- nemoci arterie carotis krev diagnostické zobrazování MeSH
- proteiny vázající mastné kyseliny krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- APOA1 protein, human MeSH Prohlížeč
- APOB protein, human MeSH Prohlížeč
- apolipoprotein A-I MeSH
- apolipoprotein B-100 MeSH
- FABP4 protein, human MeSH Prohlížeč
- proteiny vázající mastné kyseliny MeSH
BACKGROUND: Diseases caused by atherosclerosis play the most important role in mortality and morbidity worldwide. Serum adipocyte fatty acid binding protein (A-FABP) seems to be a new promising marker to determine the risk of atherosclerosis. OBJECTIVE: The aim of this study was to evaluate relationships between serum A-FABP levels in studied individuals and to assess the possibility of modeling the intima media thickness of the common carotid artery (C-IMT) using A-FABP levels and other observed characteristics. METHODS: Seventy two Caucasian individuals were enrolled and divided into 3 groups: dyslipidemic patients with or without metabolic syndrome (MetS+, n=17; MetS-, n= 34) and controls (n=21). RESULTS: There was confirmed the well-established risk profile of individuals with MetS (unfavorable lipid and lipoprotein profile, as well as increased parameters of insulin resistence and C-IMT). A-FABP concentrations in this group were significantly higher in comparison with both MetS- and controls. CONCLUSION: Using multiple linear regression models of C-IMT values for all individual data, healthy controls and dyslipidemic patients without metabolic syndrome (MetS-) A-FABP levels were not revealed as an important predictor of C-IMT in our model. In contrast, age, gender, waist circumference, nonHDL cholesterol levels and ApoB/ApoA1 ratio were important repressors of C- IMT in study individuals. This finding may be attributed to the overwhelming effect of other more robust risk factors for atherosclerosis in these individuals.
Citace poskytuje Crossref.org